Abstract
Convergent evolution of the SARS-CoV-2 Spike protein has been mostly driven by immune escape, in particular by escape to the viral infection-neutralizing antibodies (nAbs) elicited by previous infections and/or vaccinations [...].
MeSH terms
-
Antibodies, Blocking
-
Antibodies, Neutralizing
-
Antibodies, Viral
-
COVID-19*
-
Humans
-
Mutation
-
SARS-CoV-2* / genetics
-
Spike Glycoprotein, Coronavirus / genetics
Substances
-
spike protein, SARS-CoV-2
-
Spike Glycoprotein, Coronavirus
-
Antibodies, Blocking
-
Antibodies, Neutralizing
-
Antibodies, Viral
Grants and funding
This research received no external funding.